Cited by 49Adrenal Hormones and DisordersStress Responses and CortisolRheumatoid Arthritis Research and Therapies

A defect in cortisol production in rheumatoid arthritis: why are we still looking?

Jessop, D. S., Harbuz, M. S.·2005·Rheumatology

Abstract

The question of whether patients with rheumatoid arthritis (RA) might have a defective hypothalamo–pituitary–adrenal (HPA) axis was first raised when RA patients who were treated with glucocorticoids in the 1950s showed dramatic improvement in their symptoms. It was initially hypothesized that this was due to an impaired ability of RA patients to synthesize sufficient amounts of endogenous glucocorticoids, but intensive investigations over the next few decades failed to reveal any significant defects in HPA axis activity in RA patients. In our review of the literature [1] we found no compelling evidence for significant differences in either basal or stress-stimulated HPA axis activity in RA compared with normal healthy individuals. However, we did highlight an inherent defect, which resided in the inability of RA patients to mount an appropriately enhanced glucocorticoid response to increased secretion of proinflammatory cytokines such as interleukin (IL)-1, IL-6 and tumour necrosis factor (TNF)-α. ‘In other words’, we concluded, ‘the HPA axis response in RA is defective precisely because it is normal’.

Integrity signals

Registry

Crossref · 10.1093/rheumatology/keh644

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Jessop, D. S., & Harbuz, M. S.
Affiliations
University of Bristol (GB)
Corresponding author
Jessop, D. S.
Venue
Rheumatology
Published
2005-04-12
Volume
44
Issue
9
Pages
1097-1100
ISSN
  • 1462-0324 (ISSN-L)
  • 1462-0332
OpenAlex
W2122751765
Cited by
49
References
42
Citations by year
2021: 1 · 2020: 2 · 2019: 1 · 2017: 2 · 2016: 2 · 2015: 4 · 2014: 4 · 2013: 3 · 2012: 6
FWCI
0.38
Type
journal article
Language
en
Open access
closed
Locations
  • Lara D. Veeken (publishedVersion)
  • PubMed (publishedVersion)
  • Bristol Research (University of Bristol) (publishedVersion)
  • Explore Bristol Research (submittedVersion)
Funders
Wellcome Trust
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
  • Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
  • Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
Keywords
rheumatoid arthritis, hypothalamic-pituitary-adrenal axis, cortisol production, glucocorticoid response, inflammatory cytokines, interleukin-1, interleukin-6, TNF-α, glucocorticoid therapy, stress response
MeSH terms
Arthritis, Rheumatoid, Humans, Hydrocortisone, Hypothalamo-Hypophyseal System, Pituitary-Adrenal System

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review